News

We send the latest information from SMC Laboratories.

2024.08.07

PRODUCTS AND SERVICE PUBLICATION

MOA demonstration #4 【Gut-Liver Axis】|Evaluation of the efficacy of a compound in the treatment of MASH via the Gut-Liver Axis using STAM™ mice

Today, we introduce the pre-clinical studies in MASH drug development targeting Gut-Liver axis.   In MASH…

READ MORE

2024.07.24

PRODUCTS AND SERVICE

Preclinical COPD study with positive controls, Roflumilast

Today, we share an update regarding new preclinical service. It is now possible to use a positive control (Rof…

READ MORE

2024.07.19

PRODUCTS AND SERVICE PUBLICATION

The STAM™ mouse: a clinically relevant, spontaneous HCC model

We would like to introduce a study published by our client using our STAM™ mouse (Dow, et al. Proc Natl Acad S…

READ MORE

2024.07.12

PRODUCTS AND SERVICE

Introducing our skin disease model: Imiquimod (IMQ)-induced psoriasis model

Today, from our lineup of pathological models, we would like to introduce the imiquimod (IMQ)-induced dermatit…

READ MORE

2024.07.05

PRODUCTS AND SERVICE PUBLICATION

MOA demonstration #3 【GLP-1】|Evaluation of GLP-1 targeted MASH treatment efficacy using STAM™ mice

Today, we introduce the pre-clinical studies in MASH drug development targeting GLP-1.   Speaking of GLP-…

READ MORE

2024.06.26

PRODUCTS AND SERVICE

Custom Model Service and its case study “CAIA-Rheumatoid Arthritis Model”

In recent years, we have received many requests about our services, starting from the establishment of patholo…

READ MORE

2024.06.20

PRODUCTS AND SERVICE PUBLICATION

MOA demonstration #2【diponectin】|A drug efficacy evaluation study using STAM™ mice “Inhibition of MASH and fibrosis progression by adiponectin-derived peptide”.

We introduce the pre-clinical studies in MASH drug development using Adiponectin, adipoR1 , adipoR2, etc. as M…

READ MORE

2024.03.14

PRODUCTS AND SERVICE

What is the best non-clinical liver cancer model with 100% cancer incidence rate and suitable for liver cancer assessment?

If you are considering a drug evaluation study for liver cancer using a mouse model, our STAM™-HCC/IO⁺ m…

READ MORE

2024.03.12

PRODUCTS AND SERVICE

The [optimal disease model] that maximizes your research outputs.

The bleomycin-induced pulmonary fibrosis mouse model is commonly used to replicate the pathogenesis of IPF in …

READ MORE

2024.03.08

PRODUCTS AND SERVICE

【Case Study】Why do disease model mice change the outcomes?

If you are considering using a lung fibrosis model in a drug efficacy study, you can maximize the efficacy of …

READ MORE

Page 1 of 41234Last